Wells Fargo & Company Tenaya Therapeutics, Inc. Transaction History
Wells Fargo & Company
- $429 Billion
- Q1 2025
A detailed history of Wells Fargo & Company transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 44,884 shares of TNYA stock, worth $34,111. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,884
Previous 31,553
42.25%
Holding current value
$34,111
Previous $45,000
44.44%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
48.7MCall Options Held
74.4KPut Options Held
78.4K-
Column Group LLC San Francisco, CA9.4MShares$7.14 Million12.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$5.12 Million0.45% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$4.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.76MShares$3.61 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$3.1 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $31.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...